NASDAQ:BCTG BCTG Acquisition (BCTG) Stock Price, News & Analysis → Do This Today BEFORE Biden Wins in November (From Stansberry Research) (Ad) Free BCTG Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$9.88▼$11.4752-Week Range N/AVolume2,024 shsAverage Volume36,697 shsMarket Capitalization$218.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BCTG Acquisition alerts: Email Address Ad Stansberry ResearchDo This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video. About BCTG AcquisitionBCTG Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses primarily located in North America and Europe in the biotechnology industry. The company was incorporated in 2020 and is based in San Diego, California.Read More Ad Stansberry ResearchDo This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video. BCTG Stock News HeadlinesApril 7, 2024 | investopedia.comWhat Is an Acquisition Cost in Business Accounting?December 15, 2023 | seekingalpha.comENER Accretion Acquisition Corp.May 10, 2024 | Stansberry Research (Ad)Do This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).May 26, 2023 | benzinga.com(SPAC) Special Purpose Acquisition Investigation: BBAI, TNGX, SNTI, GMTX, Contact Shareholder Rights Law Firm Johnson FistelApril 29, 2023 | seekingalpha.comIntact Financial: Still Digesting The RSA AcquisitionApril 29, 2023 | cnbc.comBritain blocks Microsoft's $69 billion acquisition of Activision BlizzardMarch 8, 2023 | technews.tmcnet.comSpecial Purpose Acquisition Companies: The Briscoe Law Firm, PLLC Announce Investigation into the following SPACsFebruary 21, 2023 | benzinga.comBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Tango Therapeutics, Inc (TNGX) InvestigationMay 10, 2024 | Stansberry Research (Ad)Do This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).November 15, 2022 | seekingalpha.comTango Therapeutics: Behind The Recent MomentumAugust 25, 2022 | msn.comLiverpool office marks North West expansion for leading engineering consultancyJanuary 5, 2022 | msn.comWho's Hiring In The Ocean City Area? Browse New Local JobsAugust 13, 2021 | investing.comBctg Acquisition Corp (TNGX)August 11, 2021 | sg.finance.yahoo.comRichardson Acquires Control Chemical Corporation, a Manufacturer of Vegetable Oil-Based Drilling FluidsAugust 10, 2021 | finance.yahoo.comTango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer TherapiesJuly 29, 2021 | thestreet.comMACQ Rises on New Deal, Palantir in Two New PIPESSee More Headlines Receive BCTG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BCTG Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:BCTG CUSIPN/A CIKN/A WebN/A Phone858-400-3112FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio4.80 Quick Ratio4.80 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.23 per share Price / BookN/AMiscellaneous Outstanding Shares21,377,000Free FloatN/AMarket Cap$218.05 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Aaron I. Davis B.A. (Age 43)M.A., M.Sc., Chairman & CEO Dr. Christopher Fuglesang Ph.D. (Age 52)J.D., Pres & Director Mr. Michael Beauchamp (Age 30)CFO & Treasurer Dr. Andrew Ruel Ellis J.D. (Age 38)M.D., COO & Sec. Key CompetitorsMerrimack PharmaceuticalsNASDAQ:MACKSpartacus AcquisitionNASDAQ:TMTSRenovaroNASDAQ:RENBG1 TherapeuticsNASDAQ:GTHXAtossa TherapeuticsNASDAQ:ATOSView All Competitors BCTG Stock Analysis - Frequently Asked Questions When did BCTG Acquisition IPO? BCTG Acquisition (BCTG) raised $145 million in an initial public offering (IPO) on Thursday, September 3rd 2020. The company issued 14,500,000 shares at $10.00 per share. SVB Leerink acted as the underwriter for the IPO. This page (NASDAQ:BCTG) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BCTG Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.